Rachel Taylor

Rachel Taylor

Labour — North Warwickshire and Bedworth

Speaking in the House of Commons on 23 March 2026

Debate

Puberty Blockers Clinical Trial

Contribution

For the sake of time, I will not. The need to be guided by evidence is precisely why the current situation is so troubling. It is concerning that the MHRA initially raised no objections to the trial when it was approved but has since changed that position. As Dr Cass made clear, no new evidence has been presented to justify that shift. That raises serious questions about the basis of the decision, and whether an independent regulator has buckled to pressure from a well-funded lobbying campaign. As a consequence, vital research is now at risk, and that matters. The trials are not an optional extra; they are the mechanism through which we build the evidence base that critics say is lacking.

More from Rachel Taylor

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

For Rachel Taylor's full parliamentary record including voting history, expenses and all other contributions, see the Rachel Taylor report card.